HIV Drug Buyers Fight Bid To Combine 9th Circ. Appeal Briefs

By Matthew Perlman · May 28, 2024, 7:06 PM EDT

Drug buyers that allege Gilead Sciences Inc. and Teva Pharmaceuticals delayed generic versions of HIV medications told the Ninth Circuit it would be unfair to grant the companies' call for a...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Brief

Case Information

Case Title

In re HIV Antitrust Litigation

Case Number

Court

California Northern

Nature of Suit

Anti-Trust

Date Filed

May 14, 2019

Case Title

United Healthcare Services, Inc. v. Gilead Sciences, Inc., et al.

Case Number

Court

Appellate - 9th Circuit

Nature of Suit

Date Filed

March 18, 2024

Recent Articles By Matthew

June 24, 2024
Justices Won't Hear Objections To $2.67B BCBS Deal
June 10, 2024
Health Data Co. Says Rival's Request Risks Patient Security
June 04, 2024
Nurse Staffing Exec Wants Antitrust, Fraud Charges Separated
May 24, 2024
Software-Aided Price Fixing Under Antitrust Assault
May 16, 2024
Gilead, Teva Want 17 HIV Drug Antitrust Appeals Consolidated
May 13, 2024
2nd Circ. Affirms Dismissal Of Bystolic Antitrust Suit
May 07, 2024
MultiPlan, Insurance Cos. Accused Of Algorithmic Collusion
May 06, 2024
Biotech Co. Wants To Appeal Red Cross Antitrust Immunity
May 02, 2024
Lawmaker Wants Antitrust Probe Of Health Insurance Data Co.
April 18, 2024
EU Antitrust Chief Says Merger Tool Not A 'Power Grab'